Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats
Section snippets
Acknowledgements
This work was supported by the international collaboration grant of China Chunhui plan (No. 2004-1; No. 2004-2) and Yunnan natural science foundation (No. 2004C0002R).
References (30)
- et al.
Apoptosis in primary cultures of E14 rat ventral mesencephala: time courses of dopaminergic cell death and implications for neural transplantation
Exp. Neurol.
(1999) - et al.
Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease
Neurosci. Lett.
(2006) - et al.
Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA
Pharmacol. Biochem. Behav.
(1980) The clinical application of cell grafting techniques in patients with Parkinson's disease
Prog. Brain Res.
(1990)- et al.
The unilateral 6-hydroxydopamine lesion model in behavioral brain research: analysis of functional deficits, recovery and treatments
Prog. Neurobiol.
(1996) - et al.
Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae
Prog. Neurobiol.
(1996) - et al.
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system
Brain Res.
(1970) - et al.
The Stereotaxic Atlas of the Rat Brain
(1991) - et al.
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice
Nat. Biotechnol.
(2003) Fetal neuron grafts pave the way for stem cell therapies
Science
(2000)
Experimental models of Parkinson's disease
Nat. Rev. Neurosci.
Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis
Glia
Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats
Stem Cells
Cell replacement therapies for central nervous system disorders
Nat. Neurosci.
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model
Proc. Natl. Acad. Sci. U.S.A.
Cited by (26)
Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage
2022, Experimental NeurologyCitation Excerpt :Nonetheless, the mixed outcomes of clinical trials provide guidance for developing alternative strategies to improve cell-based therapy for PD. Human neural stem cells (hNSCs) have multiple therapeutic qualities, including production of anti-inflammatory, anti-apoptotic, pro-regenerative, pro-angiogenic, and neurotrophic growth factors (Boese et al., 2020; Boese et al., 2018; Eckert et al., 2015; Hamblin and Lee, 2021; Hamblin et al., 2022; Lee et al., 2007; Lee et al., 2020; Pluchino et al., 2005; Wei et al., 2007; Yasuhara et al., 2006). In rodent models of neonatal hypoxic ischemic injury, transplanted hNSCs extensively migrate to injury sites and some of them differentiate into neurons that integrate with the host neuronal network (Imitola et al., 2004).
Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease
2017, Behavioural Brain ResearchCitation Excerpt :Thus, other alternatives have been investigated, and one promising possibility is stem cell transplant. Many pre-clinical and clinical studies have used fetal [8–15], neural [16,17] or embryonic [18,19] cells to treat PD and have shown optimistic results. Ethical and religious concerns, however, make the use of these cellular sources inappropriate in clinical practice [20].
Stem cell therapy for amyotrophic lateral sclerosis
2015, Cell RegenerationCitation Excerpt :The integration ability and prospective therapeutic efficacy of human neural stem cells (hNSC) has been demonstrated in rodent models of neurological diseases [20–23]. Apart from regenerating lost neuronal cells, NSCs can also improve the functional outcomes of rats through auxiliary mechanisms, such as neurotrophism [24–26] and immunosuppression [27–29]. A number of studies have demonstrated that NSC therapy had beneficial effects on ALS rats [17, 30].
BDNF expression with functional improvement in transected spinal cord treated with neural stem cells in adult rats
2013, NeuropeptidesCitation Excerpt :All efforts were made to minimize the number of animals and their suffering during the experiments. NSC was obtained from the hippocampal tissue of green fluorescent protein (GFP) transgenic embryonic mouse, then incubated as described previous work (Wei et al., 2007). Briefly, the hippocampal tissues were harvested and washed in D-Hanks’ solution.
Effects of NT-4 gene modified fibroblasts transplanted into AD rats
2009, Neuroscience LettersNeural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
2023, World Journal of Stem Cells